Clinical rheumatology · 2025
Identifying plasma proteins and immunocyte phenotypes as risk factors in rheumatoid arthritis: The role of EPHA3 and CD28+ CD45RA+ CD8br treg cells.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Zhang Yanqiu, Liang Yuting, Liu Mengxue, Liu Lili, Li Jun, Li Ruyu, Wu Ziqi, Qiao Longwei, Chen Jingyu
Аннотация
OBJECTIVES: Rheumatoid arthritis (RA) is a chronic systemic autoimmune disease whose pathogenesis involves the participation of numerous plasma proteins and immune cells, but their relationships are unclear. So we set out to thoroughly examine the causal link between 4907 plasma proteins and RA and to identify the involvement of 731 immunocyte phenotypes as potential mediators.
METHODS: Using publicly available genome-wide association studies (GWAS) data, 5 Mendelian randomization (MR) methods (inverse variance weighted (IVW), weighted median, MR-Egger, simple mode, weighted mode) were applied for analysis, along with sensitivity analyses.
RESULTS: 27 plasma proteins and 10 immunocyte phenotypes were causally linked to RA, with most of the proteins serving as drug targets. Ephrin type-A receptor 3 (EPHA3) was a significant risk factor for RA (odds ratio (OR) = 1.312, 95% confidence interval (CI) [1.102, 1.562], Beta = 0.272, p < 0.01). CD28 on CD28+ CD45RA+ CD8br regulatory T (Treg) cells mediated the relationship between EPHA3 levels and RA risk, with a mediation effect of 0.029 (95% CI: -0.111, 0.169), accounting for 10.7% of total effect. Moreover, Sensitivity analyses further supported the robustness of these findings.
CONCLUSION: Plasma proteins and immunocyte phenotypes linked to RA have been identified using MR, including EPHA3, which may elevate RA risk by influencing CD28 on CD28+ CD45RA+ CD8br Treg cells. This could improve RA diagnosis and targeted therapies. Key Points • CD28 on CD28+ CD45RA+ CD8br Treg cells mediates the association between EPHA3 levels and RA risk, highlighting a novel pathway in RA pathogenesis.
METHODS: Using publicly available genome-wide association studies (GWAS) data, 5 Mendelian randomization (MR) methods (inverse variance weighted (IVW), weighted median, MR-Egger, simple mode, weighted mode) were applied for analysis, along with sensitivity analyses.
RESULTS: 27 plasma proteins and 10 immunocyte phenotypes were causally linked to RA, with most of the proteins serving as drug targets. Ephrin type-A receptor 3 (EPHA3) was a significant risk factor for RA (odds ratio (OR) = 1.312, 95% confidence interval (CI) [1.102, 1.562], Beta = 0.272, p < 0.01). CD28 on CD28+ CD45RA+ CD8br regulatory T (Treg) cells mediated the relationship between EPHA3 levels and RA risk, with a mediation effect of 0.029 (95% CI: -0.111, 0.169), accounting for 10.7% of total effect. Moreover, Sensitivity analyses further supported the robustness of these findings.
CONCLUSION: Plasma proteins and immunocyte phenotypes linked to RA have been identified using MR, including EPHA3, which may elevate RA risk by influencing CD28 on CD28+ CD45RA+ CD8br Treg cells. This could improve RA diagnosis and targeted therapies. Key Points • CD28 on CD28+ CD45RA+ CD8br Treg cells mediates the association between EPHA3 levels and RA risk, highlighting a novel pathway in RA pathogenesis.